Notes/ Discussion items:
IPR16 due Nov 18. Schedule is on wiki.
Risk Review - 100% risks reviewed (177 total risks, incl. 30 retired); 4 triggered; 0 new, 0 retired
8 PCR's submitted and approved.
No new recommendations during the reporting period - a few entered from XAB meeting (in Jira).
12 staff publications in RP1 - target for the year is 40.
No questions asked.